Connection

Perry Halushka to Shock, Septic

Back to Details
This is a "connection" page, showing publications Perry Halushka has written about Shock, Septic.
Perry Halushka
Connection Strength
1.843
Shock, Septic
  1. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study. Crit Care. 2015 Dec 18; 19:440.
    View in: PubMed
    Score: 0.123
  2. Effect of LTB4 receptor antagonists in endotoxic shock in the rat. Circ Shock. 1991 Aug; 34(4):385-92.
    View in: PubMed
    Score: 0.091
  3. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat. Eur J Pharmacol. 1991 Jun 25; 199(2):221-5.
    View in: PubMed
    Score: 0.090
  4. Effect of a LTD4 receptor antagonist in porcine septic shock. Eicosanoids. 1991; 4(3):169-75.
    View in: PubMed
    Score: 0.087
  5. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock. Circ Shock. 1990 Nov; 32(3):209-18.
    View in: PubMed
    Score: 0.086
  6. Resistance of essential fatty acid-deficient rats to endotoxin-induced increases in vascular permeability. Circ Shock. 1990 Jun; 31(2):159-70.
    View in: PubMed
    Score: 0.084
  7. The role of eicosanoids in mediating blood flow alterations in endotoxin shock. Prog Clin Biol Res. 1989; 299:33-42.
    View in: PubMed
    Score: 0.076
  8. The rat in sepsis and endotoxic shock. Prog Clin Biol Res. 1989; 299:243-52.
    View in: PubMed
    Score: 0.076
  9. Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. J Pharmacol Exp Ther. 1988 Oct; 247(1):363-71.
    View in: PubMed
    Score: 0.075
  10. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med. 1986; 12(3):116-26.
    View in: PubMed
    Score: 0.062
  11. The effects of alpha adrenergic blockade on arachidonic acid metabolism and shock sequelae in endotoxemia. Circ Shock. 1986; 20(2):151-9.
    View in: PubMed
    Score: 0.062
  12. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat. J Pharmacol Exp Ther. 1985 Nov; 235(2):470-4.
    View in: PubMed
    Score: 0.061
  13. Elevated plasma 6-keto-prostaglandin F1 alpha in patients in septic shock. Crit Care Med. 1985 Jun; 13(6):451-3.
    View in: PubMed
    Score: 0.059
  14. Sulindac does not preserve renal prostacyclin synthesis during endotoxemia. Prostaglandins. 1985 Jun; 29(6):1031-7.
    View in: PubMed
    Score: 0.059
  15. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. Circ Shock. 1985; 15(3):193-204.
    View in: PubMed
    Score: 0.058
  16. The potential role of thromboxane and prostacyclin in endotoxic and septic shock. Am J Emerg Med. 1984 Jan; 2(1):28-37.
    View in: PubMed
    Score: 0.054
  17. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism. Am J Med. 1983 Jun 14; 74(6A):91-6.
    View in: PubMed
    Score: 0.052
  18. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat. Br J Clin Pharmacol. 1983; 15 Suppl 1:133S-139S.
    View in: PubMed
    Score: 0.050
  19. Arachidonic acid metabolism in endotoxin tolerance. Adv Shock Res. 1983; 10:131-42.
    View in: PubMed
    Score: 0.050
  20. Protective effects of aspirin in endotoxic shock. J Pharmacol Exp Ther. 1981 Aug; 218(2):464-9.
    View in: PubMed
    Score: 0.045
  21. Essential fatty acid deficient rats: a new model for evaluating arachidonate metabolism in shock. Adv Shock Res. 1981; 6:93-105.
    View in: PubMed
    Score: 0.044
  22. Implications for thromboxane A2 in the pathogenesis of endotoxic shock. Adv Shock Res. 1981; 6:83-91.
    View in: PubMed
    Score: 0.044
  23. Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther. 1980 Oct; 215(1):160-4.
    View in: PubMed
    Score: 0.043
  24. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan; 65(1):227-30.
    View in: PubMed
    Score: 0.041
  25. Endotoxin tolerance: effects on lethality and macrophage thromboxane (B2) and interleukin 6 production. Shock. 1994 May; 1(5):366-71.
    View in: PubMed
    Score: 0.028
  26. Alterations in Gc levels and complexing in septic shock. Circ Shock. 1989 Jul; 28(3):249-55.
    View in: PubMed
    Score: 0.020
  27. Alterations in plasma levels and complexing of Gc (vitamin D-binding protein) in rats with endotoxic shock. Circ Shock. 1989 Jul; 28(3):279-91.
    View in: PubMed
    Score: 0.020
  28. Gi proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1--> 3)-beta-D-glucan induced cytokine suppression. Front Biosci. 2006 Sep 01; 11:2264-74.
    View in: PubMed
    Score: 0.016
  29. Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat. J Cardiovasc Pharmacol. 1986 May-Jun; 8(3):514-9.
    View in: PubMed
    Score: 0.016
  30. Differential alteration of lipoxygenase and cyclooxygenase metabolism by rat peritoneal macrophages induced by endotoxin tolerance. Prostaglandins. 1986 Apr; 31(4):639-50.
    View in: PubMed
    Score: 0.016
  31. Dazoxiben in human sepsis and adult respiratory distress syndrome. Clin Pharmacol Ther. 1985 Apr; 37(4):391-5.
    View in: PubMed
    Score: 0.015
  32. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. Surg Gynecol Obstet. 1985 Apr; 160(4):320-2.
    View in: PubMed
    Score: 0.015
  33. Experimental endotoxemia in the rat: efficacy of prostacyclin or the prostacyclin analog iloprost. Circ Shock. 1985; 16(1):1-7.
    View in: PubMed
    Score: 0.014
  34. Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock. Circ Shock. 1985; 17(1):59-71.
    View in: PubMed
    Score: 0.014
  35. Gentamicin and indomethacin in the treatment of septic shock: effects on prostacyclin and thromboxane A2 production. J Pharmacol Exp Ther. 1983 Apr; 225(1):94-101.
    View in: PubMed
    Score: 0.013
  36. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat. Br J Pharmacol. 1983 Apr; 78(4):725-32.
    View in: PubMed
    Score: 0.013
  37. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet. 1982 Jul 24; 2(8291):174-5.
    View in: PubMed
    Score: 0.012
  38. Thromboxane and prostacyclin production during septic shock. Adv Shock Res. 1982; 7:133-45.
    View in: PubMed
    Score: 0.012
  39. The improvement in endotoxin-induced redistribution of organ blood flow by inhibition of thromboxane and prostaglandin synthesis. Adv Shock Res. 1982; 7:209-18.
    View in: PubMed
    Score: 0.012
  40. Modulation of macrophage arachidonic acid metabolism: potential role in the susceptibility of rats to endotoxic shock. Circ Shock. 1982; 9(6):605-17.
    View in: PubMed
    Score: 0.012
  41. Sensitization of essential fatty acid-deficient rats to endotoxin by arachidonate pretreatment: role of thromboxane A2. Circ Shock. 1981; 8(1):69-76.
    View in: PubMed
    Score: 0.011
  42. Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Circ Res. 1980 Jun; 46(6):854-9.
    View in: PubMed
    Score: 0.010
  43. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations. Circ Shock. 1987; 22(1):55-63.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.